REGONOL Drug Patent Profile
Which patents cover Regonol, and when can generic versions of Regonol launch?
Regonol is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in REGONOL is pyridostigmine bromide. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Regonol
A generic version of REGONOL was approved as pyridostigmine bromide by IMPAX LABS on April 24th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for REGONOL?
- What are the global sales for REGONOL?
- What is Average Wholesale Price for REGONOL?
Summary for REGONOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,345 |
| Drug Prices: | Drug price information for REGONOL |
| What excipients (inactive ingredients) are in REGONOL? | REGONOL excipients list |
| DailyMed Link: | REGONOL at DailyMed |
Recent Clinical Trials for REGONOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Icahn School of Medicine at Mount Sinai | Early Phase 1 |
| National Institutes of Health (NIH) | Early Phase 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Early Phase 1 |
Pharmacology for REGONOL
| Drug Class | Cholinesterase Inhibitor |
| Mechanism of Action | Cholinesterase Inhibitors |
US Patents and Regulatory Information for REGONOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | REGONOL | pyridostigmine bromide | INJECTABLE;INJECTION | 017398-001 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
